Eileen O’Reilly, MD
Enriched profileWinthrop Rockefeller Endowed Chair in Medical Oncology; Section Head, Hepatopancreaticobiliary & Neuroendocrine Cancers, Gastrointestinal Oncology Service; Co-Director, Medical, David M. Rubenstein Center for Pancreatic Cancer Research; Chair, Human Research Protection Program and Institutional Review Board · Memorial Sloan Kettering Cancer Center
Eileen O’Reilly is Winthrop Rockefeller Endowed Chair in Medical Oncology; Section Head, Hepatopancreaticobiliary & Neuroendocrine Cancers, Gastrointestinal Oncology Service; Co-Director, Medical, David M. Rubenstein Center for Pancreatic Cancer Research; Chair, Human Research Protection Program and Institutional Review Board at Memorial Sloan Kettering Cancer Center. OpenAlex indexes 1,170 publications with 44,655 citations (h-index 102). Clarivate lists Eileen O’Reilly as a Highly Cited Researcher (Clinical Medicine, 2024-2025).
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Eileen O’Reilly is Winthrop Rockefeller Endowed Chair in Medical Oncology at Memorial Sloan Kettering Cancer Center, New York, NY. The public record shows 1,170 publications with 44,655 citations (h-index 102), centered on Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics, Cholangiocarcinoma and Gallbladder Cancer Studies. It also documents 1 NIH-funded awards (2022–2025).
- Most recent indexed publication: 2026 · JCO oncology practice
- Top research focus: Pancreatic and Hepatic Oncology Research
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 120 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 362.
Clinical & industry
trials, payments and federal fundingNot shown. No U.S. clinical registration on file.
This is a research profile, built on the published record. There's no U.S. clinical registration (NPI) on file, so facts that hang off one (clinical specialty, industry payments) aren't shown. We'd rather leave a gap than guess. Why? →
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
Rockefeller Outpatient Pavilion, 160 East 53rd Street, New York, NY 10022
Clinical trials
We didn't find any investigator roles for this person on ClinicalTrials.gov. Why? →
Industry payments
Not shown. This person has no U.S. clinical registration (NPI) on file, so we can't reliably tie industry payments reported to CMS to them. We'd rather leave a gap than guess. Why? →
NIH funding
Updated 27 Aug 2026
1 NIH research award on record, funded 2022–2025 per NIH RePORTER. The latest:
- The Memorial Sloan Kettering Cancer Center SPORE in Pancreas Cancer
Sloan-Kettering Inst Can Research
FY2025$2,434,565P50CA257881 - Homologous recombination deficiency and beyond in pancreatic cancer: evaluating the regulators of response to pembrolizumab and olaparib (POLAR) from the immune and genomic perspectives
Sloan-Kettering Inst Can Research
FY2025$591,430P50CA257881 - Determining the mechanism of pks+ E.coli-associated carcinogenesis in early onset colorectal cancer.
Sloan-Kettering Inst Can Research
FY2025$176,000P50CA257881
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Availability and Use of Social Determinants of Health Data in Alliance Gastrointestinal Cancer Clinical Trials.
JCO oncology practice
Article2026 - Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer.
Clinical cancer research
Article2026 - Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer.
Cancer discovery
Article2026
Most-cited works
by citation count (OpenAlex)- 01
- 02Pancreatic Cancer1,846 citations2021
- 03Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer1,269 citations2023
- 04
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/eileen-o-reilly-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
synapse.mskcc.org/synapse/people/6561
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →synapse.mskcc.org ↗ - Other
mskcc.org/cancer-care/doctors/eileen-o-reilly
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Mentions by others
where others cite or feature them- Other
oncodaily.com/blog/oncology-brothers-189678
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗ - Other
cancernetwork.com/view/eileen-m-oreilly-md-challenges-treating-patients-pancreatic-cancer
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancernetwork.com ↗ - LinkedIn
linkedin.com/posts/aacrjournals_meet-eileen-m-oreilly-md-senior-editor-activity-7214306513522176000-G1HL
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Internal Medicine residency
St. James's Hospital, Dublin, Ireland; Fellowship, Internal Medicine/Medical Oncology, St. Vincent's Hospital, Dublin; Fellowship, Medical Oncology …
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mskcc.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mskcc.org ↗
Editorial & leadership roles
journal and society appointments- Associate/Senior Editor
Journal of Clinical Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗ - Co-Chair
NCI Alliance Cooperative Group Gastrointestinal Cancers Committee
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗ - Member
NCI Gastrointestinal Cancers Steering Committee (GISC) and ASCO Guidelines Committee
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗
Highly Cited Researcher
Clarivate's annual list, by award category and year- Clinical Medicine20242025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mskcc.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mskcc.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vivo.weill.cornell.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acsjournals.onlinelibrary.wiley.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
- CancerNetwork feature interview: 'Eileen M. O'Reilly
MD, on the Challenges of Treating Patients with Pancreatic Cancer'
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancernetwork.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Valerie Rusch, MD
Memorial Sloan Kettering Cancer Center
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center